The 8th IPF Summit 2024 is dedicated to advancing disease-modifying pulmonary fibrosis drugs.
The 8th IPF Summit 2024 covers topics such as:
- Define more meaningful preclinical endpoints to aid identification of novel targets and development of more effective IPF therapeutics
- Effectively translate into the clinic by better recapitulating IPF through robust in vitro & vivo models
- Validate non-invasive biomarker & diagnostic techniques for back translation and ultimately achieve greater clinical benefit
The 8th IPF Summit 2024 brings together :
- Biotech
- Large Pharma
- Academics
- CROs
- Preclinical model providers
